DrugDashboards

Ipratropium Bromide Inhalation

Ipratropium Bromide Inhalation · IPRATROPIUM BROMIDE 17 ug/1 · Aerosol · Respiratory (Inhalation) · Armstrong Pharmaceuticals, Inc.

NDC 17270-0401-00 · 1 CANISTER in 1 CARTON / 200 AEROSOL in 1 CANISTER · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$10.00$20.00$30.00Jun 2026Sep 2026$22.22
3 price points · per GMSource: CMS NADAC

Supply fragility

30Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for ipratropium bromide (other) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA217953
TE code
AB
Approval date
Feb 23, 2026
Patents / exclusivity
0 patents, 1 exclusivities
TypeNumber / codeExpires
exclusivityPCOct 13, 2026

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Ipratropium Bromide Inhalation (Aerosol)

LabelerStrengthFirst seenLast seen
Armstrong Pharmaceuticals, Inc.IPRATROPIUM BROMIDE 17 ug/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Ipratropium Bromide Inhalation — NDC 17270-0401-00," retrieved September 3, 2026, https://drugdashboards.com/drug/17270040100.

Free to cite with attribution — see how the data is put together.